Health authorities and regulators are increasingly looking for much higher levels traceability during the manufacture of parenteral medicines. The most common processes and technologies applied to achieve compliance are now reaching their technical limitations and as such new approaches are needed to deliver the traceability requirements,
Traceability at the individual container level could become very important to drive patient safety through the prevention of product mix-up. There are other strong business drivers for uniquely coded containers. These include improved batch visibility and accountability whilst simplifying investigation work in case of potential deviations during fill and finish operations. This reduces risk and can limit the direct financial impact from missed revenue or drug shortages.
This copyright notice applies to all proprietary pages, images, text, programs, and other material available throughout this Internet site (collectively, this “Publication”). All materials posted on the website are subject to copyrights owned by the International Society for Pharmaceutical Engineering (“ISPE”) and other individuals or entities. Any reproduction, retransmission or republication of all or part of any documents found on this site is expressly prohibited, unless ISPE or the copyright owner of the material has expressly granted its prior written consent to reproduce, retransmit or republish the material. All other rights reserved. View entire copyright policy.
